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I thasbeenadecadesince thedevelopmentof fractional lasers.1The concept of fractional laser resurfacing was first devel-opedfromlasers forhair transplantation.These laserswereused
to make tiny 1-mm scalp wounds for placement of grafts.2 Al-
though there may be controversy over use of lasers for hair resto-
ration, it was readily apparent that the small laser wounds healed
quickly with minimal scarring.
This led to fractional laser studiesbyManstein et al1 at theWell-
man Center for Photomedicine. Initially, they evaluated the use of
groupsnonablative laser “microspots” as analternative to resurfac-
ing or using nonablative devices to treat a broader area.
Fromthisconcept, thefirstnonablativefractional laser, theFraxel
(Reliant Technologies Inc [now Solta, a subsidiary of Valeant Phar-
maceuticals]), was developed.1
This laser emits a 1550-nm wavelength, which is highly ab-
sorbed by water. As a nonablative laser it creates hundreds of
microscopic columns of thermal injury. These have been calledmi-
crothermalzones.Circumferentially surroundingeachof thesezones
isunlaseredtissue,whichcontributestotherapidhealing.After treat-
ment, reepithelialization typically occurs within 24 hours.
Withnonablative fractional laser treatments, patientsoftenex-
periencemilderythema,which resolveswithin aweek.Makeupcan
be applied shortly after treatment. Themild swelling that does de-
velop resolves in a few days, and there is minimal downtime.
Studies1,3 demonstrated rhytid reduction as well as improved
skin texture and skin tightening. In addition, the adverseeffect pro-
file was much improved compared with traditional laser resurfac-
ing.Nonablative fractional technologyexpanded thepotential suit-
ablecandidates for laser treatment.Owing to the longerwavelength
of this laser, there is lessmelanin absorption. This allows treatment
of higher Fitzpatrick skin types (types IV-VI)4 with less risk of dys-
chromia (Figure 1). Some of these lasers proved surprisingly effi-
cient in treating scars (Figure 2). Similar devices at wavelengths of
1320, 1440, and 1540 nm by other manufacturers followed.
In2007,Hantashet al5 introduced theclinical andhistologic re-
sultsof anewablative fractional carbondioxide laser. Thisbegan the
era of ablative fractional resurfacing. Unlike nonablative fractional
treatments, in which the stratum corneum remained intact, these
ablativefractionaldevicesvaporizeacompletecolumnoftissue.Frac-
tional resurfacing skin tissue contractionhasbeen shown topersist
for at least 1 year after the procedure.6,7
Frequently, patients treatedwithablative fractional lasershave
a longer recovery than those treatedwith nonablative fractional la-
sers.Dependingonmultiple treatmentandpatient variables this of-
ten requires3 to5days for reepithelializationand initial healing.Be-
cause tissues aroundeachof these lasered columnsarenotdirectly
treated, healing can occur from the tissues around the ablated
column aswell as from the base of the column. This rapid reepithe-
lialization from the untreated surrounding skin decreases the
challenges that canbe associatedwith recovery aswell as risk of in-
fection, acneiform eruptions, erythema, and scarring.8
Several studies have shown significant skin changes from frac-
tional resurfacing.Onestudy9 thatusedhigh-resolutionultrasonog-
raphy tomeasure dermal thickness revealed a 25%mean increase
in dermal thickness. At the histochemical level, fractional resurfac-
ing stimulates collagen contraction and neocollagenesis.10-12
Immunohistochemical stains showcellularmarkers for neocol-
lagenesis, proinflammatory cytokine production, metaloprotein-
ases, and type I and type III collagen.13-15Thisprocess continueswith
ongoing tissue remodeling for up to6months. In a relatedprocess,
Fractional lasers were first developed based on observations of lasers designed for hair
transplantation. In 2007, ablative fractional laser resurfacing was introduced. The
fractionation allowed deeper tissue penetration, leading to greater tissue contraction,
collagen production and tissue remodeling. Since then, fractional erbium:YAG resurfacing
lasers have also been introduced. These lasers have yielded excellent results in treating
photoaging, acne scarring, and dyschromia. With the adjustment of microspot density, pulse
duration, number of passes, and fluence, the surgeon can adjust the treatment effects. These
lasers have allowed surgeons to treat patients with higher Fitzpatrick skin types (types IV to
VI) and greater individualize treatments to various facial subunits. Immunohistochemical
analysis has demonstrated remodeling effects of the tissues for several months, producing
longer lasting results. Adjuvant treatments are also under investigation, including
concomitant face-lift, product deposition, and platelet-rich plasma. Finally, there is a short
recovery time from treatment with these lasers, allowing patients to resume regular activities
more quickly. Although there is a relatively high safety profile for ablative fractionated lasers,
surgeons should be aware of the limitations of specific treatments and the associated risks
and complications.
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skin contraction from fractional resurfacinghasbeen shown toper-
sist for 1 year after the procedure.6,7
Fractional resurfacing brought other advantages as well.
Unlike fully ablative treatments, there is minimal risk of hypopig-
mentation. Hunzeker et al8 reported a series of 2000 treatments
without a single case of case of hypopigmentation. In addition,
this same large study reported not a single incidence of scarring.
While results comparable with those of full-field traditional laser
resurfacing remained to be seen, a new viable alternative had
arisen.
Ablative Fractional Resurfacing
A variety of devices have followed for ablative fractional resurfac-
ing (AFR) since 2007. These vary in several ways including wave-
length (carbon dioxide, erbium, YSGG), delivery system (rolling vs
stamp), microspot diameter, pulse duration, density, and depth of
penetration.
Several studies16,17 have shown consistent improvement for
rhytids, photodamage, and scars. In addition, histological analysis18
has demonstrated collagen remodeling up to 3 months after the
procedure. Despite marketing claims to the contrary, studies com-
paring these devices have shownno significant differences in pain,
downtime, and, most important, results.19
In addition, several parameters can be adjusted to alter treat-
ment effects. The first is laser fluence,which is the laser energy per
unit area of tissue. Aesthetic outcome, as well as rate of complica-
tions, can vary with the fluence. The second is microspot density,
which is used to adjust the resurfaced area percentage. Microspot
density is important.Oneof themechanismsof healing is epithelial
migration from adjacent untreated skin. Furthermore, tissue cool-
ing occurs by heat transfer to the untreated area around each mi-
crospot. Dermal bulk heating varies directly with microspot den-
sity. Therefore, microspot density also affects healing and the risk
of complications.
Formostdevices, thediameter of the lasermicrospot is not ad-
justable. Another parameter is microspot pulse duration. Adjacent
tissue and dermal bulk heating also vary directly with the pulse du-
ration.
Microspots vary indiameterbetweendevices andcanablate to
avariabledepth into thedermis.Withmicrospot technology,depths
of up to2000μmhavebeenachieved.8 Thepercentageof the skin
surface area that is ablated can also be varied. The higher the den-
sity, thehigher thepercentageof skin treated.Dependingon thede-
sign parameters of the fractional laser, increasing resurfacing den-
sity beyond a certain level will more closely approximate carbon
dioxide laser resurfacing.As such, there canbean increase in recov-
ery time and risk profile.
Increasing the percentage of treated area can be achieved by
increasing the density or using more than 1 pass to achieve a
greater percentage of lasered area. Using more than 1 pass to
increase the surface area treated allows for dermal cooling
between passes. The thermal effects of using more than 1 pass to
increase the percentage of treated surface area differ from that of
increasing the density.
Figure 1. A 38-Year-OldWomanWith Fitzpatrick Type IV SkinWhoUnderwent 5 Treatments
With the Fraxel Laser
Before treatment After treatment
Figure 2. A PatientWhoUnderwent 5 TreatmentsWith the Fraxel Laser
Before treatment After treatment
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Pulse duration also can have a significant effect on clinical re-
sults. Tierney et al20 performed a study to analyze the effect ofmi-
crospot pulse duration on depth of resurfacing. Ten patients were
treated with an ablative fractional carbon dioxide laser. The pulse
duration was randomized from 500 to 1800 microseconds. Flu-
ence and density were constant. Postauricular skin biopsies were
taken 1 hour, 1week, and8weeks after treatment.Histologic analy-
sis revealed that greater pulse duration yielded an increase in abla-
tiondepth.Althoughnotevaluated in this study,20 it shouldbenoted
that increased pulse duration increases adjacent tissue thermal ef-
fects and dermal bulk heating.
Fluence can also affect depth of ablation as well as diameter.
Hantash et al5 performed an ex vivo histologic study evaluating the
effect of changes in fluence. In this study, they found that with the
fractional carbondioxide laser studied, a 150% increase inpulseen-
ergy from 9.2 to 23.3 resulted in a 66% increase in ablation diam-
eter. This also resulted in a 99% increase in ablative depth.
Laser Treatment Parameters
It is not possible to give one set of parameters that can be used in
most patients to achieve a predicted outcome. Skin varies among
anatomical locations and patients.
Ablative Fractional Resurfacing Indications
Photoaging
Ablative fractional resurfacinghasdemonstratedexcellent improve-
ment in thetreatmentofphotoaging21,22 (Figure3).AstudybyClem-
entoni et al17 showed not only excellent improvement in photoag-
ing in a large series, but also persistence of the results 2 years after
treatment. We have found that after fractional carbon dioxide re-
surfacing, patients continue to improve for at least 6 months. This
is consistent with the reported histochemical effects of fractional
resurfacing.13,14
A broad study looking at 4 different manufactured brands of
fractional resurfacingdevices (Fraxel Repair [SoltaMedical Inc], Ac-
tive andDeep FX [Lumenis], Quadralase [Candela], and Pearl Frac-
tional [Cutera]) demonstrated consistent improvement in photoa-
ging treated with ablative fractional devices.19 Consistent
improvement was noted in skin texture, lentigines, pore size, and
rhytids. Inaddition, itwasnotedthatall4of thecommonlyusedfrac-
tional devices resulted in statistically the same downtime and
results.
Acne Scarring
A wide variety of devices were used to treat acne scars in the
past, both ablative and nonablative.23 Ablative fractional resur-
facing offers the unique advantage over other systems of safe
penetration into the low reticular dermis allowing for deep skin
remodeling.
Studies have demonstrated consistent improvement of acne
scarswith fractional lasers. A study24 evaluating the effect of treat-
ment intervals foundsignificant improvement inacnescarswith frac-
tional carbon dioxide laser. Thirteen patients received 2 treat-
ments at either 1- or 3-month intervals for acne scarring. In addition
to noting clinically significant improvement in all patients, no dif-
ference in clinical results or adverse effectswasnotedbetween the
2 groups. In another study25 of 15 patients treated formoderate to
severe acne scarring, 66.8% had an improvement after 2 to 3 full-
face fractional carbon dioxide laser treatments. In patients with
ice-pick scars fromacne, Trimas26 recommended surgical excision,
followed by carbon dioxide laser resurfacing.
Otherscars, includingsurgical scars,havebeentreatedwith frac-
tionated lasers.Aprospectiveblindedstudy27of 15patients treated
with fractional carbon dioxide for postsurgical scars noted clini-
cally significant improvement in the treated half of the scar. An-
other study28usinganonablative 1550-nmlaserdemonstratedclini-
cally significant improvements inboth thepatient and independent
observer appreciation of scar pigmentation and/or color, thick-
ness, irregularity, and relief.
Product Deposition
The channels created by fractional resurfacing can be used for the
introductionofproducts into the skin,whichwasnotpossible in the
past. In 1 studyof the treatment foracnescarring.Waibel etal29used
these channels to allow deeper penetration of topical corticoste-
roids.Theyreportedthat thisenhancedtheoutcomeof treatingwith
a fractional laser.Amore recent studybyRkeinetal30usedthis same
concept todeliver topicallyappliedpoly-L-lactic acid (PLLA) through
the skin. They reported a seemingly synergistic benefit of ablative
fractional laser resurfacing and PLLA in the treatment of atrophic
scarring.Evenafter thesestudies, there is still controversyabout this
type of product deposition.
Platelet-Rich Plasma
Another recent study31 evaluated theeffectsofplatelet-richplasma
(PRP) administration on posttreatment healing time and adverse
events in patients undergoing fractional carbon dioxide laser using
the forearm as the test site. Postoperatively, patients treated with
PRP were noted to have decreased edema and improved ery-
thema, in comparisonwith those treatedwith saline. Reepitheliali-
zation rateswerenoted tobesimilarbetweenthePRP-treatedareas
and controls. Further research is necessary to assess such effects
when the procedure is performed on the face.
Dyschromia
After fractional resurfacing,within24to48hours, keratinocytesand
stem cells migrate from adjacent nonlasered tissue into ablated
zones.Healingalsooccurs fromthedeeper skin appendages. These
healing mechanisms have an “averaging” effect on dyschromia,
thereby giving the skin a more even pigmentation.
This theory of “melanin shuttle” has been most beneficial
with the nonablative fractional devices. Several studies32,33 have
demonstrated a reduction in melasma with these devices. It
should be noted that this does not affect the tendency to form
melasma. Thus, even after treatment, it is possible for melasma to
recur in the future.
Reductiondoes requiremultiple treatments.Astudy34hasdem-
onstrated effective treatment ofmelasma in Chinese patientswith
limited results. Despite this study, we are still cautious about treat-
ing these patients with a fractional carbon dioxide laser, consider-
ing thepossible risk of inducingdyschromia. Benefits havebeen re-
ported for other types of pigmentation as well.35,36
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Combined Surgical Procedures
For years, the idea of resurfacing the skin at the same time as sur-
gical lifting remained controversial. Gradually, some surgeons be-
gan tocombine the2with successful andsafe results. In2002,Koch
and Perkins37 reviewed the literature and provided their own suc-
cessful series todemonstrate thesafetyofperforminga face-lift and
simultaneous full-face carbon dioxide laser resurfacing.
It seemedonly logical to combine the less invasive fractional re-
surfacingwith lifting procedures. In 2012, Truswell38 presented his
experience of combining full-face AFR with simultaneous face-lift.
In a series of 42 patients, there were no incidence of hypopigmen-
tation, infection, or skin necrosis. Four patients had hyperpigmen-
tation, all ofwhich resolvedwithoutconsequence. Inaddition,other
procedures performed at the same time included endoscopic fore-
head-lift, upper and lower blepharoplasty, and chin augmentation
(Figure 4). Truswell38 emphasized the importance of technique to
Figure 3. A PatientWhoUnderwent Full-Face Fractional TreatmentWith the Carbon Dioxide Laser at a Setting
of 100mJ, Density 3; 80mJ, Density 3; Periorbital
Before treatment After treatment
Before treatment After treatment
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preserve flapvascularity. This involved insuringa thick flap,decreas-
ing laser energy, and feathering over elevated tissue.
Others have reported safely combined AFR and face-lifting.
Duplechain39went further, combining resurfacingwith surgery and
volumerestoration.Thiscombinationof liftingwith resurfacing (frac-
tional or full field) could be combinedwith fat grafting for maximal
rejuvenation.Duplechain39 recommendedagainstusing thesmaller
spot size with the Lumenis Encore laser. This is a deeper penetrat-
ing fractional laser on a skin flap.
We believe that the safety of simultaneous fractional resurfac-
ing over an elevated face-lift flap is technique- and technology-
dependent. Therefore, if performed, thisprocedure shouldbedone
judiciously (Figure 5).
Fractional Laser Technique
One of themainmechanisms for skin rejuvenation by fractional re-
surfacing is to achieve sufficient thermal stimulation of the dermis
whileminimizing the risk of complications. In terms of specific pro-
cedural technique, there aremultiple variables that should be con-
sidered. These will affect both the details of the procedure as well
as the laser parameters.
There is considerable skinvariationamongpatients.This can re-
late to several factors, includingbutnot limited to thepatient’s age,
social habits, skin care,prior sunexposure, Fitzpatrick skin type, and
medical conditions. For example, an older patientwith thinner skin
cannot tolerate the same treatment as someone in his or her 40s
who has thicker, more robust skin.
Evenon the samepatient, skin varies depending on specific lo-
cation.Forexample, compare lowereyelid skinwith immediatelyad-
jacent cheek skin. They are very different. These variations should
be consideredwhenever performing a laser procedure to optimize
the outcome andminimize the chance of complications.
Laser Skin Care
Pre–Laser Treatment Skin Care
Every attempt is made to start patients on a preoperative regi-
men a full month in advance. Patients may be started on a bleach-
ing cream (hydroquinone, 4%) daily in advance of their proce-
dure, especially if the patient has a darker skin type. Patients can
also be scheduled for a glycolic acid peel 2 to 4 weeks prior to
their laser treatment.
Post–Laser Treatment Care
Following the laser procedure, patients are instructed in a specific
regimenofskincare.For thosepatientsundergoingnonablative frac-
tional resurfacing, care isminimal.We recommendusingamild, fra-
grance-free cleanser and moisturizer for the first week after treat-
ment.Strict sunavoidance isemphasized.Followingweek1,patients
may resume their regular skin care regimen.
For those patients undergoing ablative fractional resurfacing,
patients begin a process of frequent cleaning. Some surgeons will
recommend using just tap water and gentle gauze followed by ap-
plicationof abland lubricatingointment, suchasAquaphor (Beiers-
dorf Inc) or petrolatum.Otherswill use antifungal and/or antibiotic
solutions, such as dilute acetic acid (1 tspwhite vinegar in 2 cups of
water). Patients are encouraged to shower at least once a day. This
is continueduntil resurfacing is complete, typically betweendays4
to 6 after the procedure.
Once resurfacing is complete, patients are encouraged towear
mineral-basedmakeup. Gentle, fragrance-free cleansers andmois-
turizers are recommended until all redness has faded. Patients can
be started on a topical steroid (hydrocortisone, 2%) to helpwith ir-
ritation andwell as expedite fading of erythema.During this period
patients are strongly urged to avoidprolonged sunexposure and to
wear sunscreen daily.
Figure 4. Full-Face Fractional Carbon Dioxide Laser Treatment
at a Setting of 100mJ, Density 3, Face; 80mJ, Density 3, Periorbital;
and Transconjunctival Lower Blepharoplasty
Before treatment After treatment
Before treatment After treatment
Figure 5. Cheek Skin Following Face-lift and Full-Face Fractional Carbon
Dioxide Laser Resurfacing at a Setting of 100mJ, Density 3
Before treatment After treatment
Clinical Review& Education Review Current Status of Fractional Laser Resurfacing
364 JAMA Facial Plastic Surgery September/October 2015 Volume 17, Number 5 (Reprinted) jamafacialplasticsurgery.com
Copyright 2015 American Medical Association. All rights 
Copyright 2015 American Medical Association. All rights reserved.
Once erythemahas faded, patients are encouraged to continue
with a regular skin care regimen that includes sunscreen and at least
1 prescription-strength product. Tretinoin or retinol products are an
excellentchoiceformostpatients.Patientsarealsoencouragedtofol-
low good skin care practices, including sun avoidance.
Regular Use of Sunscreen and Avoidance of Tanning
Previous studies have documented the importance of prophylactic
therapy,even in thosewithoutahistoryofherpetic infections.All pa-
tients are placed on antiviral prophylaxis. This begins the day before
their procedure in thosewithout a history of herpetic infections and
3 days before in those with a history of herpetic infections. Valacy-
clovir is typically usedbecauseof theeaseof the twice-a-daydosing.
Therapy is continued for a total of 10 days.
Fractional Carbon Dioxide Laser vs Carbon Dioxide
Laser Resurfacing
Nonfractional carbondioxide resurfacing lasers require a longer re-
covery and have a higher adverse effect profile than fractional ab-
lative resurfacing or nonablative lasers. However, it should also be
noted that they can produce amore dramatic result.39 Ablative re-
surfacing can be performed with the carbon dioxide or erbium:
yttrium-aluminum-garnet (Er:YAG) lasers. Ablative laser resurfac-
ing is most commonly used for photoaging, rhytids, laxity, and
scarring.While rhytids anddyschromiasarehighly responsive toab-
lative resurfacing, scars may be less responsive.3,40
Even with the advent of fractional carbon dioxide resurfacing,
there is still a role for ablative full-field carbon dioxide laser resurfac-
ing. Patients undergoing this procedure shouldbehighlymotivated.
Inhavingthisprocedure,patientsareanticipatingamoredramatic re-
sult,andtheyarealsoacceptinga longerrecoveryandassociatedrisks.
Theyshouldbewillingtowearmakeupuntil thepostresurfacingpink-
ness resolves.Theyalso shouldhavea lifestyle that allowsavoidance
orat leastextremecautionwithsunexposure.Theseare typicallypa-
tients in their late 50s to70swhohavea lifestyle that allows themto
have the recovery time and havemoderate to deep rhytidswith sig-
nificant associated actinic changes.
Alternatively, thepatientundergoingfractional resurfacing istypi-
callysomeonewithanactive lifestylewhocannottaketimefromtheir
busyschedulefora longerandmore involvedrecovery.Thesepatients
would feel constrained if they had to consider daily camouflage
makeup.Thepatientundergoingfractional laserresurfacingfrequently
isnotwilling to take time fromtheirbusyschedule fora longer recov-
ery.Most of the first author’s patients prefer fractional resurfacing.
Complications
One of the main advantages of fractional resurfacing has been the
lower incidence of complications, especially with the nonablative
devices.1 Studieswith ablative fractional devices also show a lower
riskprofile than full-field ablative resurfacing.8 That said, complica-
tions still remain an issue. In a retrospective study41 of 374 patients
whohaddeepresurfacingwitha fractional carbondioxide laser there
were adverse events in 16.8% of patients. These included acne-
iformeruptions, herpes simplexeruptions, bacteria andcandida in-
fections, hyperpigmentation, persistent erythema, and contact
dermatitis. In the study by Campbell and Goldman42 of 287 pa-
tients, 13.9% experienced complications, including allergic or
contact dermatitis, acneiform eruptions, persistent erythema, and
herpes simplex.
Even though the resulting numbers from these studies are sig-
nificant, theyrepresentsa loweroveralloccurrenceofadverseevents
and better safety profile than the fully ablative laser resurfacing la-
serswitha36%incidencerateofhyperpigmentation,3 themostcom-
mon adverse effect.
It should be noted that cervical skin, with fewer pilosebaceous
units andadifferent blood supply than the face, is at greater risk for
complications. This increases in the lower two-thirds of the neck.
Avramet al43 reported 5 cases of patientswhopresented for treat-
ment of hypertrophic scarring of the neck following fractional ab-
lative resurfacing. Duplechain39 highlighted these differences and
recommendedcautionwith resurfacing,especially in the lowerneck.
Treatment of the neck with fractional resurfacing should be ap-
proached with caution, lower fluence, lower density, and shorter
pulse duration settings.
Treatment with lasers, as with any other surgical procedure,
can lead to undesirable outcomes and patient dissatisfaction,
possibly resulting litigation. A recent review44 of laser-related liti-
gation demonstrated that permanent injury and disfigurement
were the 2 most cited alleged factors. More than half of the cases
were from cutaneous treatments, with age-related changes, acne
scars, and hair removal the most frequent indications leading to
lawsuit.
Conclusions
With the introduction of fractional technology, we have entered a
new era of laser skin rejuvenation. Studies have shown that frac-
tional treatments offer patients many of the same benefits of tra-
ditional carbon dioxide laser resurfacing with less downtime and a
lower riskprofile.The idealpatientshavemild tomoderatesundam-
age, superficial rhytids, are still active and in the sun, and accepting
ofmore subtle improvement. This new technologywill continue to
evolvewith altered treatment parameters and new systems.While
there remains a place for those desiring themaximal results of tra-
ditional full-field ablative carbon dioxide laser resurfacing, the fu-
ture is bright for most patients looking for the alternative options
that current fractional resurfacing devices provide.
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